European Union

Insights on the Non-Destructive Testing Global Market for the Infrastructure Industry to 2026 - Growth in Infrastructure Maintenance Services is Driving Growth - ResearchAndMarkets.com

Tuesday, April 13, 2021 - 6:56pm

The plant produced 11.65 lakh metric tons of rails in the financial year 2019-2020.

Key Points: 
  • The plant produced 11.65 lakh metric tons of rails in the financial year 2019-2020.
  • The projects aim to reduce the noise generated by freight trains, develop and improve cross-border railway links, and upgrade crucial infrastructure in ports.
  • They will be supported through the Connecting Europe Facility (CEF), the EU's financial mechanism supporting transport infrastructure.
  • The growth of the construction industry is expected to create potential opportunities for the growth of the market.\n"

Aquavit Wins a Trademark Case over AQUAGOLD in European Union Intellectual Property Office Against a Counterfeiter

Thursday, April 15, 2021 - 4:45pm

b'NEW YORK, April 15, 2021 /PRNewswire/ --The European Union Intellectual Property Office (EUIPO) declared that U-BioMed\'s falsely registered AQUAGOLD European Union trademark (No.

Key Points: 
  • b'NEW YORK, April 15, 2021 /PRNewswire/ --The European Union Intellectual Property Office (EUIPO) declared that U-BioMed\'s falsely registered AQUAGOLD European Union trademark (No.
  • 17902149) is invalid in its entirety, as it was originally created and owned by Aquavit Pharmaceuticals, Inc. ("Aquavit").
  • The division concluded that "the [Aquavit\'s] application was totally successful and U-BioMed\'s European Union trademark has been declared invalid for all the contested goods.
  • "\nAquavit\'s microchannel technology, AQUAGOLD, was launched in 2014 at the American Academy of Dermatology, the largest dermatology conference in the world.

BioInvent's partner Oncurious NV presents Phase I data on TB-403 in pediatric cancer

Monday, April 12, 2021 - 6:44am

TB-403 has an Orphan Designation for medulloblastoma from the European Medicines Agency (EMA).

Key Points: 
  • TB-403 has an Orphan Designation for medulloblastoma from the European Medicines Agency (EMA).
  • For further information and the complete press release, please visit https://www.oncurious.com/news-events/latest-news .\nTB-403 is an anti-PIGF (anti-placenta growth factor) antibody and it is currently in development by Oncurious NV, a subsidiary of Oxurion NV.
  • TB-403 was formerly jointly developed by BioInvent and Oncurious but is, as previously informed, no longer one of BioInvent\'s focus projects.
  • More information is available at www.bioinvent.com .\n'

BioInvent's partner Oncurious NV presents Phase I data on TB-403 in pediatric cancer

Monday, April 12, 2021 - 6:41am

TB-403 has an Orphan Designation for medulloblastoma from the European Medicines Agency (EMA).

Key Points: 
  • TB-403 has an Orphan Designation for medulloblastoma from the European Medicines Agency (EMA).
  • For further information and the complete press release, please visit https://www.oncurious.com/news-events/latest-news .\nTB-403 is an anti-PIGF (anti-placenta growth factor) antibody and it is currently in development by Oncurious NV, a subsidiary of Oxurion NV.
  • TB-403 was formerly jointly developed by BioInvent and Oncurious but is, as previously informed, no longer one of BioInvent\'s focus projects.
  • More information is available at www.bioinvent.com .\n'

ESMA PUBLISHES INTERIM TEMPLATES FOR STS SYNTHETIC SECURITISATION NOTIFICATIONS

Saturday, April 10, 2021 - 8:00am

09 April 2021

Key Points: 
  • 09 April 2021

    Securitisation

    The European Securities and Markets Authority (ESMA), the EUs securities and markets regulator, has published the interim simple, transparent and standardised (STS) notification templates for synthetic securitisations following amendments to the Securitisation Regulation (SECR).

  • The interim templates allow originators to notify ESMA of synthetic securitisations that meet the STS criteria.
  • Until the date of the application of the Regulatory Technical Standards (RTS) specifying the content and the format of STS notifications for synthetic securitisations, originators can make the necessary information available to ESMA in writing during the interim period.
  • ESMA makes available, in its website (LINK to the STS securitisation notification section), interim STS synthetic notification templates that originators can use to ensure consistency across all STS notifications.

ESMA PUBLISHES INTERIM TEMPLATES FOR STS SYNTHETIC SECURITISATION NOTIFICATIONS

Saturday, April 10, 2021 - 12:02am

09 April 2021

Key Points: 
  • 09 April 2021

    Securitisation

    The European Securities and Markets Authority (ESMA), the EUs securities and markets regulator, has published the interim simple, transparent and standardised (STS) notification templates for synthetic securitisations following amendments to the Securitisation Regulation (SECR).

  • The interim templates allow originators to notify ESMA of synthetic securitisations that meet the STS criteria.
  • Until the date of the application of the Regulatory Technical Standards (RTS) specifying the content and the format of STS notifications for synthetic securitisations, originators can make the necessary information available to ESMA in writing during the interim period.
  • ESMA makes available, in its website (LINK to the STS securitisation notification section), interim STS synthetic notification templates that originators can use to ensure consistency across all STS notifications.

ESMA PUBLISHES ANNUAL PEER REVIEW OF EU CCP SUPERVISION

Friday, April 9, 2021 - 12:03am

08 April 2021

Key Points: 
  • 08 April 2021

    CCP Directorate

    Supervisory convergence

    The European Securities and Markets Authority (ESMA), the EUs securities markets regulator, has today published itsannual peer review reporton the supervision of EU Central Counterparties (CCPs) by National Competent Authorities (NCAs).

  • The Peer Review measured the effectiveness of NCA supervisory practices in assessing CCP compliance with EMIRs requirements on liquidity stress testing.
  • However, the peer review showed that the assessment of some areas of liquidity stress testing was not always performed or being evidenced sufficiently.
  • The CCP Supervisory Committee is mandated to conduct, at least annually, a peer review analysis of the supervisory activities of all NCAs in relation to the authorisation and the supervision of CCPs in accordance with Article 30 of Regulation (EU) No 1095/2010 (ESMA Regulation).

ESMA PUBLISHES DRAFT REGULATORY TECHNICAL STANDARDS ON CHANGES TO CCPS’ ACTIVITIES AND MODELS

Friday, April 9, 2021 - 12:02am

The European Securities and Markets Authority, the EUs securities markets regulator, today published its Final Report containing draft regulatory technical standards (RTS) relating to changes to central counterparty (CCP) services and activities, as well as models and parameters under the European Markets Infrastructure Regulation (EMIR).

Key Points: 
  • The European Securities and Markets Authority, the EUs securities markets regulator, today published its Final Report containing draft regulatory technical standards (RTS) relating to changes to central counterparty (CCP) services and activities, as well as models and parameters under the European Markets Infrastructure Regulation (EMIR).
  • Prior to making any significant change to its risk models or parameters, a CCP must also obtain validation from its competent authority and ESMA (Article 49).
  • The European System of Central Banks, the European Banking Authority and other relevant authorities have contributed to the drafting of the RTS.
  • ESMA submits the draft RTS to the European Commission for endorsement, following which the Commission Delegated Regulation will be subject to the non-objection of the European Parliament and the Council.

ESMA makes recommendations for Organised Trading Facilities under MiFID II/MiFIR

Friday, April 9, 2021 - 12:02am

08 April 2021

Key Points: 
  • 08 April 2021

    MiFID - Investor Protection

    MiFID - Secondary Markets

    The European Securities and Markets Authority (ESMA), the EUs securities markets regulator, has today published its Final Report on the functioning of Organised Trading Facilities (OTFs).

  • The report contains recommendations and possible amendments to MiFID II/MiFIR with a view to reducing the level of complexity for market participants and making the legal framework more effective.
  • While some proposals can be implemented by ESMA directly by publishing ESMA guidance, other recommendations are addressed to the European Commission (EC).
  • In this context, ESMA puts forward a two-step approach aiming at clarifying the trading venue perimeter.

ESMA PUBLISHES ANNUAL PEER REVIEW OF EU CCP SUPERVISION

Friday, April 9, 2021 - 12:02am

08 April 2021

Key Points: 
  • 08 April 2021

    CCP Directorate

    Supervisory convergence

    The European Securities and Markets Authority (ESMA), the EUs securities markets regulator, has today published itsannual peer review reporton the supervision of EU Central Counterparties (CCPs) by National Competent Authorities (NCAs).

  • The Peer Review measured the effectiveness of NCA supervisory practices in assessing CCP compliance with EMIRs requirements on liquidity stress testing.
  • However, the peer review showed that the assessment of some areas of liquidity stress testing was not always performed or being evidenced sufficiently.
  • The CCP Supervisory Committee is mandated to conduct, at least annually, a peer review analysis of the supervisory activities of all NCAs in relation to the authorisation and the supervision of CCPs in accordance with Article 30 of Regulation (EU) No 1095/2010 (ESMA Regulation).